Clinical Trial Update: Phase I/II Clinical Study of 1A46 Drug Substance [Phase 1]

View source ↗

Summary

Phase I/II study of the 1A46 drug substance for advanced malignancies has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasms

Drugs mentioned

• 1A46 (1A46)

Snippet

Sponsor: BioRay Pharmaceutical Co., Ltd. | Conditions: Advanced Malignancies | Phase 1 | Status: TERMINATED